Market Recap: Monday, April 13 — Stocks Rally on Hopes for Iran Deal as Biotech and Chip Stocks Lead
Stocks rose Monday as investors bet on a resolution to U.S.-Iran tensions. Revolution Medicines surged 41% on a cancer drug breakthrough.
Market Overview
Stocks started the week on a positive note Monday as investors grew more optimistic about a potential resolution to the U.S.-Iran standoff that has rattled energy markets in recent weeks. President Trump's comments that Iran still wanted to make a deal helped lift sentiment, pushing all three major indexes higher. The tech-heavy NASDAQ led the way, gaining just over 1%, while a breakthrough cancer drug trial and a wave of analyst upgrades added fuel to the rally.
Index Performance
| Index | Close | Change |
|---|---|---|
| S&P 500 (SPY) | $686.00 | +0.98% |
| NASDAQ (QQQ) | $617.33 | +1.01% |
| Dow Jones (DIA) | $482.20 | +0.61% |
The NASDAQ's outperformance reflected continued strength in technology and AI-related names, while the Dow lagged due to its heavier weighting toward industrial and financial stocks.
What Drove the Market Today
Geopolitical Optimism
The biggest story behind Monday's gains was growing hope that the U.S.-Iran conflict may be nearing a resolution. After weekend peace talks, President Trump indicated that Iran remained open to negotiations. The Strait of Hormuz — a critical shipping lane for roughly 20% of the world's oil — has been disrupted for weeks, pushing energy prices higher. Investors are betting that a deal could ease those disruptions and bring energy costs back down, which would be welcome news after last Friday's hotter-than-expected inflation report showed energy prices as the main driver of rising costs.
Tech and AI Momentum
Technology stocks continued to attract attention Monday. Intel was one of the most actively traded stocks on the market, with over 111 million shares changing hands. The chipmaker has surged roughly 51% in just eight trading days, fueled by analyst upgrades from Benchmark and Cantor Fitzgerald, a $14.2 billion buyback of its Irish manufacturing facility, and an expanded partnership with Google to support next-generation AI and cloud systems. Nokia also saw massive volume — over 152 million shares — after Bank of America upgraded the stock to a "buy" rating, citing growing demand for optical and AI networking infrastructure and Nokia's partnership with Nvidia on 6G technology.
Biotech Breakthrough
Revolution Medicines delivered the day's most dramatic single-stock move after reporting positive results from a late-stage clinical trial for its pancreatic cancer drug, daraxonrasib. Patients taking the drug lived a median of 13.2 months compared to 6.7 months for those on standard chemotherapy — nearly doubling survival time while reducing the risk of death by 60%. The daily pill met all of its primary and secondary goals in the trial.
Today's Top Movers
Gainers
- RVMD (Revolution Medicines) surged 41.35% to $136.30 after its pancreatic cancer drug daraxonrasib delivered strong Phase 3 trial results. Jefferies raised its price target to $140 from $88.
- LNZA (LanzaTech Global) gained 25.30% to $34.02. The sustainable fuels company has been volatile in April, having jumped 47% earlier in the month on operational milestones and grant funding.
- ORCX rose 25.29% to $29.53. The move came without widely reported news catalysts.
- SNDU climbed 24.54% to $47.85. This leveraged ETF tracks SanDisk and amplifies the underlying stock's daily moves.
- CRDU gained 24.76% to $29.98. No clear news catalyst was identified.
Losers
- AFJKU fell 40.58% to $40.73, and its common stock AFJK dropped 27.86% to $40.40. The SPAC had spiked 142% on April 9, and the continued selloff reflects profit-taking after that dramatic run-up.
- NPT declined 23.13% to $7.93 without a widely reported catalyst.
- IREZ fell 19.29% to $18.08. No clear public explanation was available for the move.
- HSPTU dropped 15.89% to $8.47. The reason for the decline was not immediately clear from public news sources.
Most Active Stocks
- NOK (Nokia) led with nearly 153 million shares traded after Bank of America's upgrade.
- NVDA (Nvidia) traded 134 million shares as AI infrastructure spending remained a dominant theme.
- INTC (Intel) saw 112 million shares amid its multi-week rally on foundry partnerships and analyst upgrades.
- BITO (ProShares Bitcoin Strategy ETF) traded 105 million shares, reflecting interest in cryptocurrency-linked products.
- TZA (small-cap bear ETF) saw 101 million shares, suggesting some defensive positioning despite the broader rally.
What This Means for You
Monday's rally shows how quickly sentiment can shift on geopolitical developments. Just last Friday, markets were flat ahead of weekend peace talks — a few encouraging comments later, and all three indexes posted solid gains. For everyday investors, this is a reminder that short-term moves are often driven by headlines rather than changes in the underlying economy.
This recap is AI-generated from verified market data and publicly available news sources. It is not financial advice. Always do your own research or consult a qualified financial advisor.
This content is for educational purposes only. It is not financial advice. Always do your own research or consult a qualified financial advisor.